This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
From studies that underscore the therapeutic potential of cannabis to political changes that bode well for patients and consumers, there is much to celebrate. Before we close the books on 2018, let’s take a look back at ten of the most significant developments over the past year from ASA’s perspective and consider their impact.
Members of the House and Senate have approved versions of House Bill 364 , which allows qualified patients the option to grow marijuana at home. The measure permits registered patients (or their designated caregivers) to cultivate up to three mature plants in a private location that it not subject to public view. Chris Sununu.
Medical marijuana can alleviate certain side effects and, some research indicates, reduce the number of seizures a patient experiences. In 2018, the FDA began recommending a cannabinoid-based medication that would treat seizures associated with two rare forms of epilepsy that typically affect children. appeared first on.
The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. MPAA) the states leading voice for patient rights and cannabis policy reform. decrease from peak enrollment.
This week Americans for Safe Access released “ Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws.” The report reviews existing laws and regulations and laws passed in between January 1, 2017 and December 31, 2017, giving states letter grades from “A” to “F.”
Published in Nature Partner Journals and sponsored by the Parkinson’s Foundation, the study found that nearly 25% of Parkinson’s patients had used cannabis in the past six months, but that one in four of that group did not know what type or form of cannabis they used, and nearly half did not know their dosage. Of the 43.9% Altogether, 24.5%
This life threatening condition can also occur after a patient receives a blood transfusion or other forms of transplanted tissue from a genetically different person. Graft-versus-host disease ( GVHD ) is a common – and potentially fatal – complication following bone marrow and solid organ transplants.
In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day. Transfering nurses’ skills to cannabis medicine.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
This life threatening condition can also occur after a patient receives a blood transfusion or other forms of transplanted tissue from a genetically different person. Graft-versus-host disease ( GVHD ) is a common – and potentially fatal – complication following bone marrow and solid organ transplants.
In the majority of jurisdictions that regulate cannabis marketplaces, lawmakers in recent weeks have designated these operations to be ‘essential’ to the health and well-being of the patient community. ” You can send a message to your lawmakers in support of this effort by clicking here.
Adapted from The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience (Routledge, 2019) by Michelle Newhart and William Dolphin. In January 2018, “medical marijuana” appeared roughly 1,750,000 times to a mere 567,000 hits for “medical cannabis.” comes with the territory.
Virginia’s medical cannabis program , which currently affords patients, caregivers, and processors only an affirmative defense, will also see potential for robust expansion to improve patient access. “Virginia spent over $100M in 2018 enforcing prohibition, which flies in the face of public opinion.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Minnesota investigators identified the presence of the oil additive in 24 of the products used by 11 patients with the lung disease. Virtually all of the patients interviewed in the study acknowledged obtaining THC vape products on the underground market.
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”
As reported earlier , HB4161 focuses mainly on safety concerns, including permits, licensing, testing, taxes, and a new Hemp Social Equity Fund, but HB4161 also contains amendments that would affect registered Illinois medical cannabis patients and cottage hemp operators as well. Seeds may not be given or sold to any other person.”
November 1, 2018, was a day for celebration. Unfortunately, a year has passed and only a handful of patients have actually been prescribed cannabis. With one stroke, the British government finally cast aside years of outdated dogma, moving ‘ Cannabis Based Medicinal Products’ from Schedule 1 to Schedule 2.
In a statement issued this week, a representative from the Administration acknowledged , “With the exception of businesses that produce or sell hemp and hemp-derived products (Agriculture Improvement Act of 2018, Public Law 115-334), marijuana-related businesses are not eligible for SBA-funded services.”
However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Visiting patients also need to pay a $50 application fee.
State lawmakers have approved a series of bills reducing penalties for marijuana possession offenses and strengthening and expanding legal protections for medical cannabis patients. Senate Bill 406 expands medical cannabis access and provides important new patient protections. The measures now await action from Democratic Gov.
Under the law, which voters approved in 2018, regulators must license a minimum of 24 dispensaries in each of Missouri’s eight congressional districts. Regulators have already registered 27,000 patients to participate in the cannabis access program. Licensed dispensaries are expected to be operational by this spring.
It was referred to the Senate Judiciary Committee on 3/22/2018 and is still stuck in committee. The bill was voted out of committee on 11/26/2018 and is now on its second floor reading and waiting for a scheduled vote. 10 would expand patients’ access to medical cannabis through several means. Companion bills S.
The decision reverses a 2018 ruling by the Arizona Court of Appeals. … It is implausible that voters intended to allow patients with these conditions to use marijuana only if they could consume it in dried-leaf/flower form. ounces of hashish.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. Then, in 2017 and 2018, Virginia finally made some moves to establish its own medical marijuana industry. JM Pedini | Photo by Adam Ewing.
Other provisions in the measure explicitly permits VA physicians to provide information to patients regarding their eligibility in clinical trials, and provides a “safe harbor” for universities, clinicians, and patients participating in federally-approved trials from federal interference.
In 2018 there were nearly 24,000 adults arrested for less than 30 grams of cannabis. Cannabis consumers – even registered medical patients – regularly enduring deep discrimination by property owners and employers. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. .”
Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Even still, the “odds of a cancer patient using marijuana in the past year were essentially flat between 2013 and 2018.”
Such purposes must, however, ensure the availability of cannabis (not referenced specifically, but included in the definition of “drugs”) to patients for relief from pain and suffering. The Single Convention doesn’t mandate prohibition—it mandates regulation. In 2020, the U.N.
Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. percent versus 44.8 percent versus 3.4
By the end of 2018 there were almost 60,000 patients, and nearly $100 million had been taken in the first year of sales. It is projected that there will soon be over 200,000 registered medical marijuana patients in Maryland. Every Maryland Dispensary That MMJ Patients Need To Know. Let’s dive in! Is MMJ Legal In Maryland?
Since 2018, voters have attempted to pass adult use but have failed. Mary Schneider (D) cleared the House in an 86-6 vote this March, allowing terminally ill patients to use proof of their admittance in hospice care in lieu of a doctor’s written recommendation to register as a medical cannabis patient. Doug Burgum (R).
The questions : Initiative 65 (citizen initiated) : Should Mississippi allow qualified patients with debilitating medical conditions, as certified by Mississippi licensed physicians, to use medical marijuana? Under this proposal, patients would be prohibited from smoking whole-plant marijuana. ounces of cannabis per 14-day time period.
The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Eligible people with MS are being denied the option to try it,” the authors of the report wrote.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Although the federal legality of these products has been a matter of debate, the 2018 Farm Bill signed into law last year officially took hemp and CBD from hemp off of the federal controlled substances list. In response, veterinarians and others concerned for patient safety promoted a change in state law. Related story.
I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? Although products containing 0.3% A simple question.
Milk’s legacy lives on every time a nurse, patient, or healer dares to say, “We deserve better”—and works to make it so. Peron, 2018; “1996 California Proposition 215,” 2025) Another trailblazer was Mary “Brownie Mary” Rathbun, a retired waitress turned cannabis advocate. 2018, January 28). Milk Foundation). Her motto? “I
However, such facilities are typically only open to either state-qualified patients or to adults in states that legally regulate whole-plant cannabis sales. By contrast, CBD-infused products sold at state-licensed dispensaries are typically subject to state-specific regulations and lab testing protocols.
Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. She found that cannabis was an effective therapeutic option for helping chronic pain patients, especially seniors, decrease their dependence on opioids. “It
16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.
High Court rejects petition asking to allow patients to grow cannabis at home. This morning the judges of the High Court rejected the petition submitted by 8 patients demanding to allow them and the other holders of the license to use cannabis to grow the cannabis themselves, in their home, for their personal use.
A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content